Work

A Study of Kyv-101, a CD19 CAR T Cell Therapy, in Participants with Treatment Refractory Progressive Multiple Sclerosis

Year: 2024
Type: conference-abstract
Source: Blood
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W4405034820
Cites:
Cited by: 11
Related to: 10